29,154 trials (keyword fallback)
COVID-19 · Corona Virus Infection
Primary: Participants Who Had a Reaction to an Initial or Additional Dose of the Pfizer-BioNTech or Moderna COVID-19 mRNA Vaccine, or Who Had Long COVID — 71; 2; 1; 1 Participants
Long COVID
Primary: Change in Functional Improvement Post-COVID-19 Over Time — 8.4; 21.05; 4.55; 6.6 score on a scale — p=.06
HIV-1-infection · COVID-19
Primary: Number of Composite Primary End Point (Critical Care Admission, Palliative Discharge When Discharged From Hospital, or Mortality Within the 6 Weeks After Diagnosis of…
COVID-19 · Vaccine-Preventable Diseases · SARS CoV 2 Infection
Primary: Number of Symptomatic SARS-CoV-2 Infections Between Randomized, Study-vaccinated Participants and the Comparator Group — 48; 94 Participants
COVID-19
Primary: Percentage of Participants With Sustained Nasopharyngeal (NP) Swab Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Ribonucleic Acid (RNA) < Lower Limit of…
COVID-19
Primary: Recommended Testing Proportion — 0.66 proportion of times tested asrecommended
Covid19
Primary: Difference in Days Alive and Out of Hospital — 29.5; 29.4 days
Influenza · COVID-19
Primary: Cohort 1: Percentage of Participants With Any Local Reactions for up to 7 Days Following Vaccination in Investigational Vaccine Extremity — 74.7; 59.1 Percentage of…
Covid19
Primary: Total Number of Tests Among Network Members Referred for COVID Testing (Network Tested). — 444; 437; 196; 206 Participants
Covid19
Primary: Number of Patients With Early Clinical Improvement — 111; 80 Participants — p=<0.03
Sars-Cov2 Antibodies in Children and Adolescents Living With HIV
Primary: Number of Participants With at Least One Positive SARS-CoV-2 Antibody Test. — 563 Participants
Immunization; Infection · Pregnancy Related · COVID-19
Primary: Rate of COVID-19 Vaccination (6 Month) — 251; 130 Participants
Quality of Life · Injection Site Reaction · Adverse Drug Event
Primary: Total Number of Participants With Moderate or More Severe Fever, Chills, Myalgia, or Arthralgia in the Simultaneous Group and the Sequential Group Following Both…
COVID-19
Primary: Number of Participants With Clinical Response in Maximum Temperature (Tmax) — 8; 16 Participants
COVID-19
Primary: Number of Participants Classified Based on Education